|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
Heatley Road, Oxford Science Park, Oxford, England OX4 4GE, GB
|
|
OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Science Enterprises.
|
OMass Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used OMass Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact OMass Therapeutics customer service number in your country click here to find.
Hayley Davies is the CEO of OMass Therapeutics. To contact Hayley Davies email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.